Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 16,039 | 13,478 | 13,135 | 14,249 | 11,371 |
| Operating Income | -16,039 | -13,478 | -13,135 | -14,249 | -11,371 |
| Other Income | 3,082 | 1,868 | 1,828 | 1,385 | 661 |
| Pre-tax Income | -12,957 | -11,610 | -11,307 | -12,864 | -10,710 |
| Net Income Continuous | -12,957 | -11,610 | -11,307 | -12,864 | -10,710 |
| Net Income | $-12,957 | $-11,610 | $-11,307 | $-12,866 | $-10,710 |
| EPS Basic Total Ops | -0.24 | -0.28 | -0.28 | -0.32 | -0.26 |
| EPS Basic Continuous Ops | -0.24 | -0.28 | -0.28 | -0.31 | -0.26 |
| EPS Diluted Total Ops | -0.24 | -0.28 | -0.28 | -0.32 | -0.26 |
| EPS Diluted Continuous Ops | -0.24 | -0.28 | -0.28 | -0.31 | -0.26 |
| EBITDA(a) | $-16,709 | $-13,725 | $-13,417 | $-14,288 | $-11,136 |